S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:TWST

Twist Bioscience (TWST) Stock Price, News & Analysis

$34.31
-0.17 (-0.49%)
(As of 03/28/2024 ET)
Today's Range
$34.00
$35.09
50-Day Range
$32.28
$41.50
52-Week Range
$11.46
$43.21
Volume
1.19 million shs
Average Volume
949,821 shs
Market Capitalization
$1.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.40

Twist Bioscience MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.0% Upside
$37.40 Price Target
Short Interest
Bearish
20.77% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.60mentions of Twist Bioscience in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$294,282 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.17) to ($2.81) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.74 out of 5 stars

Medical Sector

669th out of 938 stocks

Biological Products, Except Diagnostic Industry

113th out of 153 stocks

TWST stock logo

About Twist Bioscience Stock (NASDAQ:TWST)

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

TWST Stock Price History

TWST Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
TWST Apr 2024 42.500 put
TWST Jul 2024 42.500 call
TWST Mar 2024 25.000 call
TWST Mar 2024 45.000 put
Twist Bioscience Is Poised for a Rally: How to Play It
Twist Bioscience: A 'Hold' In DNA Data Storage
Twist Bioscience Shareholders Elect Directors, Approve Compensation
Twist Bioscience: Strong Performance In A Soft Market
Twist Bioscience price target raised by $6 at JPMorgan, here's why
Twist Bioscience Corp (TWST)
Q1 2024 Twist Bioscience Corp Earnings Call
See More Headlines
Receive TWST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/02/2024
Today
3/28/2024
Next Earnings (Estimated)
5/03/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TWST
Fax
N/A
Employees
919
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$37.40
High Stock Price Target
$45.00
Low Stock Price Target
$27.00
Potential Upside/Downside
+7.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-204,620,000.00
Pretax Margin
-77.99%

Debt

Sales & Book Value

Annual Sales
$245.11 million
Book Value
$10.86 per share

Miscellaneous

Free Float
55,552,000
Market Cap
$2.01 billion
Optionable
Optionable
Beta
1.64
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Emily Marine Leproust Ph.D. (Age 50)
    Co-Founder, Chairman & CEO
    Comp: $1.37M
  • Dr. Patrick John Finn Ph.D. (Age 52)
    President & COO
    Comp: $943.94k
  • Ms. Paula  GreenMs. Paula Green (Age 56)
    Senior Vice President of Human Resources
    Comp: $618.48k
  • Dr. William Charles Banyai Ph.D. (Age 69)
    Senior VP of Advanced Development, GM of Data Storage & Director
    Comp: $711.34k
  • Mr. Adam Laponis (Age 47)
    Chief Financial Officer
  • Mr. Robert F. Werner (Age 51)
    VP & Chief Accounting Officer
  • Mr. Siyuan Chen
    Chief Technology Officer
  • Dr. Aaron K. Sato Ph.D.
    Chief Scientific Officer
  • Mr. Chet Gandhi
    Chief Information Officer
  • Mr. Dennis Cho (Age 53)
    Senior VP, General Counsel, Secretary and Chief Ethics & Compliance Officer
    Comp: $537.93k

TWST Stock Analysis - Frequently Asked Questions

Should I buy or sell Twist Bioscience stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TWST shares.
View TWST analyst ratings
or view top-rated stocks.

What is Twist Bioscience's stock price target for 2024?

4 Wall Street research analysts have issued 1-year target prices for Twist Bioscience's shares. Their TWST share price targets range from $27.00 to $45.00. On average, they predict the company's share price to reach $37.40 in the next twelve months. This suggests a possible upside of 9.0% from the stock's current price.
View analysts price targets for TWST
or view top-rated stocks among Wall Street analysts.

How have TWST shares performed in 2024?

Twist Bioscience's stock was trading at $36.86 at the beginning of the year. Since then, TWST shares have decreased by 6.9% and is now trading at $34.31.
View the best growth stocks for 2024 here
.

When is Twist Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our TWST earnings forecast
.

How were Twist Bioscience's earnings last quarter?

Twist Bioscience Co. (NASDAQ:TWST) released its quarterly earnings data on Friday, February, 2nd. The company reported ($0.75) EPS for the quarter, beating analysts' consensus estimates of ($0.78) by $0.03. The company had revenue of $71.50 million for the quarter, compared to analysts' expectations of $67.59 million. Twist Bioscience had a negative trailing twelve-month return on equity of 32.16% and a negative net margin of 78.44%. The business's revenue was up 31.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.74) earnings per share.

What guidance has Twist Bioscience issued on next quarter's earnings?

Twist Bioscience issued an update on its second quarter 2024 earnings guidance on Friday, February, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.0 million-$71.0 million, compared to the consensus revenue estimate of $70.1 million.

What is Emily Leproust's approval rating as Twist Bioscience's CEO?

44 employees have rated Twist Bioscience Chief Executive Officer Emily Leproust on Glassdoor.com. Emily Leproust has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Twist Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), DocuSign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO).

When did Twist Bioscience IPO?

Twist Bioscience (TWST) raised $75 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen served as the underwriters for the IPO and Allen & Company and Baird were co-managers.

Who are Twist Bioscience's major shareholders?

Twist Bioscience's stock is owned by many different institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.48%), Vanguard Group Inc. (9.47%), Vanguard Group Inc. (9.47%), Artisan Partners Limited Partnership (6.44%), Sumitomo Mitsui Trust Holdings Inc. (6.20%) and Nikko Asset Management Americas Inc. (6.20%). Insiders that own company stock include Dennis Cho, Emily M Leproust, Emily M Leproust, James M Thorburn, Jan Johannessen, John P Molloy, Keith Crandell, Mark Daniels, Nicolas Barthelemy, Patrick John Finn, Patrick Weiss, Paula Green, Robert Chess, Robert F Werner and William Banyai.
View institutional ownership trends
.

How do I buy shares of Twist Bioscience?

Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TWST) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners